Capital beach hundreds of billions of medical supply chain finance industry threshold into the biggest constraint

In addition to Flying Medical Network, Huaye Capital, Guofa shares and other companies are actively layout of medical supply chain finance. Most of the pharmaceutical suppliers are small and medium-sized enterprises, financing is difficult, and medical institutions accounts receivable cycle is longer, bad debt rate is low, medical supply chain finance intervention space is very large.
"the current medical supply chain financial market is very large, we forecast that the hospital this year's procurement of materials between 1.3 trillion yuan to 1.5 trillion yuan. "At the 2017 China Hospital Association Information Network Conference (CHIMA 2017), held from August 18 to 20, Ou Jianxiong, co-founder and president of Fei medical network, told the 21st Century Economic Report.
the National Health Statistics Yearbook issued by the National Health Planning Commission, the cost of purchasing hospital materials reached 1.22 trillion yuan in 2014, with an average annual growth rate of more than 40% from 2010 to 2014. According to the annual growth rate of about 20% conservative estimate, in 2017 the national hospital material procurement costs will also reach 1.5 trillion yuan, the medical supply chain financial growth soil thick. Southwest Securities Research Report also believes that the domestic medical supply chain finance ushered in a golden opportunity, the market size of hundreds of billions of levels.
, a number of companies, including Huaye Capital and Guofa, are entering the medical supply chain financial sector. Zhu Guoguang, an analyst in the pharmaceutical industry at Southwest Securities, pointed out that most of the pharmaceutical suppliers are small and medium-sized enterprises, financing is difficult, and the accounts receivable period of medical institutions is longer, the bad debt rate is low, and the intervention space of medical supply chain finance is very large.
O Jianxiong also believes that the medical supply chain financial services can improve the lean management of hospitals, reduce hospital operating costs, while providing financial services for suppliers to ensure that their operations are not interrupted and the whole supply chain healthy and stable development, "the threshold of the medical industry is high, capital needs to have an in-depth understanding of the industry, hospitals and suppliers to do a good job in the integration of resources or the key to success."said it would sign 2,000 hospitals in three years
and that Fei medical network, which had just received 40 million yuan in financing, appeared at the chiMA2017 Beijing Group's booth. During the reporter's interview, a number of hospital officials are consulting with the staff of The Flying Medical Network, and reached a preliminary intention to cooperate.
From the above-mentioned staff's presentation, we can see that the fei medical network business vertical coverage of medical institutions department planning, storage and storage, procurement process, supplier procurement, clinical department consumption, financial payables, regulatory business and other aspects of management;
understand that the "medical supply chain cloud platform" for medical supplies, the construction of cloud supply chain system, to help traditional hospital digital transformation. At present, the company has signed 200 hospitals, there are 3000 suppliers, the total amount of merchandise transactions exceeded 3 billion yuan.
" the current medical supply chain financial market is very large, this year Flying Medical Network will sign 500 hospitals, three years later we will sign up to 2000 hospitals above the second A, so that the company in the industry to form a scale advantage. Mr Ou said. The financing of the aforementioned flying medical network will be used to continue to expand the market and tap the medical supply chain market.
, a head of the materials department of a hospital in Xinjiang, told the 21st Century Economic Report that hospitals are now actively advocating information technology to improve efficiency and save costs. "Our hospital is already working with an information technology company, but we want a better overall solution, so compare it again."
it is understood that many hospitals at the moment the level of material management development is not balanced, some hospitals need to move from a pure manual, semi-manual state to the state of information support. "Several people in the hospital materials section only manage the procurement, storage, and the actual supplies application materials section may not know that there may be accounts broken, so that the original account management, out of the report there are many challenges." Ou Jianxiong pointed out.
with the introduction of the Guidance of the General Office of the State Council on the Pilot of the Comprehensive Reform of Urban Public Hospitals, it is called for the promotion of fine management of hospitals. The mechanism of "picking, managing and using" medical materials needs to be changed urgently, and hospitals need to improve the degree of refinement of hospital procurement material management through IT means.
hospital suppliers need to solve the supply efficiency, speed up turnover, and actively manage hospital inventory. Mr Ou said small and medium-sized pharmaceutical circulation companies, which account for 60 per cent of the market share, faced a shortage of operating capital, unsecured mortgages and no door to borrowing as a result of the long accounts receivable cycle.
Guojin Securities Research Report shows that the balance of accounts receivable of Chinese industrial enterprises in 2016 is about 11.5 trillion yuan, and as the non-performing loan ratio of commercial banks has climbed since 2014 to 1.75 percent in March 2016, it is close to the 2 percent warning line of banking risk, which means that banks will pay more attention to loan control, capital flow to credit good, low debt ratio of large enterprises, small and medium-sized enterprises financing more difficult.Capital beach medical supply chain finance
in Ou Jianxiong's view, although small and medium-sized pharmaceutical distributors have a long accounts receivable cycle problem, but it is facing the target is public hospitals, belonging to the national credit endorsement of public welfare institutions, and has nearly 100% repayment capacity. Public hospitals as buyers of accounts receivable debt rating is high, the risk of providing accounts receivable factoring services for public hospital suppliers is also very low, so the medical supply chain finance has a great survival ground.
" suppliers and hospitals have a long-term buy-and-sell relationship, will continue to supply, the two sides are also real transactions. The period of account formation is assumed to be six months. Accounts receivable during this period can be used to finance financial institutions without physical collateral, purely based on data and credit. Then the financial institution according to a certain discount rate, loan, call the supplier. The hospital's payments are returned to financial institutions until repayments are made, greatly reducing the pressure on suppliers to make repayments. Ou Jianxiong explained to the 21st Century Economic Reporter.
21st century economic reporter combed found that, in addition to flying medical network, Huaye Capital, Guofa shares and other companies are actively layout of medical supply chain finance.
As early as 2015, Huaye Capital announced the establishment of a medical finance platform of no more than 20 billion yuan, around the medical health and medical supply chain financial industry investment, Guofa shares in March 2016 announced the acquisition of 100% of Henan Debao, the latter is an innovative medical device supplies smart supply chain service provider, docking supply chain finance, the formation of Internet of Things technology plus cloud platform model.
although many capitals are optimistic and try to cut into the medical supply chain finance, many enterprises business development is not smooth. According to the 21st Century Economic Report reporters understand that a pharmaceutical company in 2015 also set up a medical supply chain financial direction company, for pharmaceutical enterprises, pharmaceutical distributors to provide financial services. But at present, the volume of business is gradually shrinking, only about 1 billion yuan in size.
" because of compliance issues, almost all of the assets in the past are not done, replaced with small assets projects, medicine is not the only sector, is currently in the transition stage, adding business in other industries. "The head of the above-mentioned company recently told the 21st century economic reporter.
addition to traditional enterprises in the layout of medical supply chain finance, more Internet finance companies are also cutting into this segment, targeting the same current pharmaceutical agents some of the pain points. For example, on August 19th, Youyou Supply Chain Finance issued a financing product for medical and health industry agents, "Medical e-melt".
Youyou related person in charge said that the product is in the context of the new medical reform and two-vote system and other New Deal, for hospitals and agents face many new problems and new changes, by the user friend supply chain finance division and youyou medical joint research and development, to the medical industry agents customized financing solutions to solve the problem of agent capital pressure, working capital shortage. Li Zhi, chairman of the
Jingyi Group, believes that the main difficulty of the breakthrough in the medical supply chain is how to cut into the hospital, only close institutions with medical services can really cut into the hospital market, when insurance to do direct medical compensation has not been cut into the hospital, they can not do IT, spend a lot of energy to access so many hospitals, so more is with the third-party platform cooperation. "The healthcare supply chain may be bigger than the market for health insurance and claims, and there is a lot of room for growth."
An industry analyst also pointed out that at present, similar pharmaceutical industry enterprises, pharmaceutical circulation enterprises, although they can provide relevant platforms, but their own IT technology reserves are not sufficient, and face regulatory disputes, and some HIS, HRP system manufacturers can also provide material management modules, but the overall function is simple to meet the needs of hospitals; As a result, healthcare supply chain cloud platform companies have an advantage. (21st Century Economic Report)